← FDA Drug Approvals (Drugs@FDA)

MIRABEGRON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUNSHINE LAKE PHARMA CO LTD · Approved 2025-12-10

Drug application

FDA Application #
ANDA216757
Application type
Abbreviated New Drug Application (Generic)
Brand name
MIRABEGRON
Generic name
Mirabegron
Active ingredients
MIRABEGRON
Dosage form
TABLET, EXTENDED RELEASE
Route
—
Marketing status
None (Tentative Approval)
Sponsor
SUNSHINE LAKE PHARMA CO LTD
First approval
2025-12-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown